EICHORCondition: Dermatitis, Atopic · Sponsor: Sun Pharmaceutical Industries Limited
This is a Phase II, randomized, double-blind, placebo-controlled study in subjects with moderate to severe atopic dermatitis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Omni Dermatology | Phoenix, Arizona, United States | — |
| Yuma Clinical Trials, LLC | Yuma, Arizona, United States | — |
| T. Joseph Raoof Md, Imc./Encino Research Center | Encino, California, United States | — |
| Metropolis Dermatology | Los Angeles, California, United States | — |
| Axis Clinical Trials | Los Angeles, California, United States | — |
| Providence Clinical Research | North Hollywood, California, United States | — |
| Unison Clinical Trials | Sherman Oaks, California, United States | — |
| Providere' Research Inc. | West Covina, California, United States | — |
| Clarity Dermatology | Castle Rock, Colorado, United States | — |
| Accel Research Sites Network - Annexus Dermatology & Aestheitcs | DeLand, Florida, United States | — |
| Revival Research Corporation | Doral, Florida, United States | — |
| Advanced Clinical Research Institute | Florida City, Florida, United States | — |
+ 46 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04684485